Epi proColon regulatory update

FDA approved a PMA from Epigenomics for its Epi proColon blood-based colorectal cancer screening test. Epigenomics and Polymedco Inc. (C ortlandt Manor, N.Y.) will jointly market Epi proColon in the ...